Shares of Moderna Inc. MRNA, -18.73% slid 0.78% to $345.92 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index COMP, 0.62% rising 1.04% to 15,811.58 and the Dow Jones Industrial Average DJIA, -0.26% rising 0.29% to 36,157.58. Moderna Inc. closed $151.57 short of its 52-week high ($497.49), which the company reached on August 10th.
The stock underperformed when compared to some of its competitors Wednesday, as AbbVie Inc. ABBV, -0.87% rose 0.89% to $117.57, Amgen Inc. AMGN, -1.89% rose 1.81% to $218.13, and AstraZeneca PLC ADR AZN, -0.44% rose 0.42% to $63.83. Trading volume (6.4 M) remained 5.6 million below its 50-day average volume of 12.0 M.